Acrobiosystems for English
icon_bulk_orderConsulta masiva/Pedido rápido
user
  1. Cuadro de mandos
  2. Mi perfil
  3. Mi dirección
  4. Mis pedidos
  5. Afiliación a Acro
Iniciar sesión Registro
Promotion
Recombinant Proteins ClearClear history
Recombinant Proteins CloseClose
Browse Products By Molecule Name a-zA-Z
TL1A Hot |GMP IL-2 Hot |FcRn Binding Kit (TR-FRET) New |Claudin 18.2
0
No hay productos en el carro de la compra
Mi carro|Check Out
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Casa > TSLP

TSLP

Brief Information

Name:Thymic stromal lymphopoietin
Target Synonym:Thymic stromal lymphopoietin,TSLP
Number of Launched Drugs:1
Number of Drugs in Clinical Trials:16
Lastest Research Phase:Approved

Product ListCompare or Buy

Product> Filter Results
Por estado del producto :
Por categoría de producto :
Por especies :
Por etiqueta :
Por Conjugado::
Cat. No. Especies Descripción del producto Estructura Pureza Característica
CEA-C074 Human ClinMax™ Human TSLP ELISA Kit
TSP-H5243 Human Human TSLP Protein (R127A, R130A), His Tag (MALS verified)
TSP-H5243-structure
TSP-H5243-sds
TSP-R52H3 Rat Rat TSLP Protein, His Tag
TSP-R52H3-structure
TSP-R52H3-sds
TSP-C82E3 Cynomolgus Biotinylated Cynomolgus TSLP Protein, His,Avitag™
TSP-C82E3-structure
TSP-C82E3-sds
TSP-M82E3 Mouse Biotinylated Mouse TSLP Protein, His,Avitag™
TSP-M82E3-structure
TSP-M82E3-sds
TSP-C52H8 Cynomolgus Cynomolgus TSLP Protein, His Tag
TSP-C52H8-structure
TSP-C52H8-sds
TSP-C52H4 Cynomolgus Cynomolgus TSLP (R127A, R130S) Protein, His Tag (HPLC verified)
TSP-C52H4-structure
TSP-C52H4-sds
TSP-C52H4-hplc
TSP-M52H8 Mouse Mouse TSLP Protein, His Tag (MALS verified)
TSP-M52H8-structure
TSP-M52H8-sds
TSP-H5255 Human Human TSLP (R127A, R130A) Protein, Mouse IgG2a Fc Tag (MALS verified)
TSP-H5255-structure
TSP-H5255-sds
TSP-H82E0 Human Biotinylated Human TSLP (R127A, R130A) Protein, His,Avitag™ (MALS verified)
TSP-H82E0-structure
TSP-H82E0-sds
TSP-H52Ha Human Human TSLP (R127A, R130A) Protein, His Tag (MALS verified)
TSP-H52Ha-structure
TSP-H52Ha-sds
TSP-H52Hb Human Human TSLP Protein, His Tag, premium grade
TSP-H52Hb-structure
TSP-H52Hb-sds
TSP-H82Eb Human Biotinylated Human TSLP Protein, His,Avitag™ (MALS verified)
TSP-H82Eb-structure
TSP-H82Eb-sds
ACRO Quality

Part of Bioactivity data

TSP-H52Hb-Cell-based assay
TSLP CELL

Response to human TSLP protein (Fold).
The TSLPR (Luc) HEK293 Reporter Cell was stimulated with serial dilutions of Human TSLP Protein, His Tag, premium grade (AcroBiosystems, Cat. No. TSP-H52Hb). The max induction fold was approximately 45.15 (Routinely tested).

Protocol
TSP-H52Ha-SPR
TSLP SPR

Captured Human TSLP (R127A, R130A), His Tag (Cat. No. TSP-H52Ha) on CM5 Chip via anti-His antibody, can bind Human TSLP R, Fc Tag (Cat. No. TSR-H525a) with an affinity constant of 4.22 nM as determined in SPR assay (Biacore T200) (Routinely tested).

Protocol
TSP-H52Hb-SPR
TSLP SPR

Captured Human TSLP Protein, His Tag, premium grade (Cat. No. TSP-H52Hb) on CM5 Chip via anti-His antibody, can bind Human TSLP R, Fc Tag (Cat. No. TSR-H525a) with an affinity constant of 1.81 nM as determined in SPR assay (Biacore T200) (Routinely tested).

Protocol

Customer Reviews

Synonym Name

TSLP

Background

Thymic stromal lymphopoietin (TSLP) is an epithelial cell-derived cytokine involved in the pathology of inflammatory skin diseases, and is widely expressed by epithelial cells. Human TSLP cDNA encodes a 159 amino acid (aa) residue precursor protein with a 28 aa signal sequence (4, 5). Human TSLP has been shown to developing nondeletional central tolerance, amplifying epithelium-induced class switching, inducing atopic diseases and maintaining intestinal noninflammatory environment. Among diverse cells responding to Human TSLP, CD11c+ dendritic cells are the most obviously characterized target cells.

Clinical and Translational Updates

Public Drug Information

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Tezepelumab AMG-157; MEDI-9929 Approved Amgen Inc Tezspire United States Asthma Astrazeneca Ab 2021-12-17 Immune System Diseases; Hypersensitivity; Dermatitis, Atopic; Hypersensitivity, Immediate; Bronchial Diseases; Pulmonary Disease, Chronic Obstructive; Sinusitis; Respiratory Hypersensitivity; Asthma; Eosinophilic Esophagitis; Lung Diseases, Obstructive; Lung Diseases; Respiratory Tract Diseases; Nasal Polyps; Nose Diseases; Chronic Urticaria; Anaphylaxis; Carcinoma; Granulomatosis with Polyangiitis Details
Tezepelumab AMG-157; MEDI-9929 Approved Amgen Inc Tezspire United States Asthma Astrazeneca Ab 2021-12-17 Immune System Diseases; Hypersensitivity; Dermatitis, Atopic; Hypersensitivity, Immediate; Bronchial Diseases; Pulmonary Disease, Chronic Obstructive; Sinusitis; Respiratory Hypersensitivity; Asthma; Eosinophilic Esophagitis; Lung Diseases, Obstructive; Lung Diseases; Respiratory Tract Diseases; Nasal Polyps; Nose Diseases; Chronic Urticaria; Anaphylaxis; Carcinoma; Granulomatosis with Polyangiitis Details

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Ecleralimab CSJ-117; NOV-14 Phase 2 Clinical Novartis Pharma Ag Asthma; Pulmonary Disease, Chronic Obstructive Details
WIN-1001X WIN-1001X Phase 2 Clinical Whanin Pharmaceutical Co Ltd Nerve Degeneration; Parkinson Disease Details
PF-07275315 PF-07275315 Phase 2 Clinical Pfizer Inc Dermatitis, Atopic Details
Lunsekimig SAR-443765 Phase 2 Clinical Sanofi Asthma; Inflammation Details
Bosakitug BSI-045B; TQC-2731; TQC2731 Phase 2 Clinical Biosion Inc Nasal Polyps; Sinusitis; Asthma; Dermatitis, Atopic Details
SHR-1905 SHR-1905; AIO-001 Phase 2 Clinical Shanghai Hengrui Pharmaceutical Co Ltd Nasal Polyps; Nose Diseases; Respiratory Tract Diseases; Sinusitis; Asthma Details
CM-326(Connaught Biomedical Technology) CM-326 Phase 2 Clinical Keymed Biosciences Co Ltd Nose Diseases; Nasal Polyps; Asthma; Sinusitis; Pulmonary Disease, Chronic Obstructive; Dermatitis, Atopic Details
PF-06342674 RN-168; PF-6342674; PF-06342674; ZB-168 Phase 1 Clinical Pfizer Inc Diabetes Mellitus, Type 1; Multiple Sclerosis Details
HBM-9378 SKB378; HBM-9378 Phase 1 Clinical Harbour Biomed, Sichuan Kelun-Biotech Biopharmaceutical Co Ltd Asthma Details
IBI-3002 IBI3002; IBI-3002 Phase 1 Clinical Innovent Biologics(Suzhou) Co Ltd Asthma Details
GB-0895 GB-0895 Phase 1 Clinical Generate Biomedicines Inc Immune System Diseases; Asthma Details
STSA-1201 STSA-1201; STSA1201 Phase 1 Clinical Staidson(Beijing) Biopharmaceuticals Co Ltd Asthma Details
LQ043H LQ043H Phase 1 Clinical Shanghai Novamab Biopharmaceuticals Co Ltd Asthma Details
GR2002 GR2002 Phase 1 Clinical Genrix (Shanghai) Biopharmaceutical Co Ltd Nasal Polyps; Asthma; Sinusitis; Dermatitis, Atopic Details
AZD-8630 AZD-8630; AMG-104 Phase 1 Clinical Astrazeneca Plc, Amgen Inc Asthma Details
QX-008N QX008N; QX-008N Phase 1 Clinical Qyuns Therapeutics Co Ltd Asthma; Pulmonary Disease, Chronic Obstructive Details
BD-9 BD-9 Biolojic Design Inc Details
Ecleralimab CSJ-117; NOV-14 Phase 2 Clinical Novartis Pharma Ag Asthma; Pulmonary Disease, Chronic Obstructive Details
WIN-1001X WIN-1001X Phase 2 Clinical Whanin Pharmaceutical Co Ltd Nerve Degeneration; Parkinson Disease Details
PF-07275315 PF-07275315 Phase 2 Clinical Pfizer Inc Dermatitis, Atopic Details
Lunsekimig SAR-443765 Phase 2 Clinical Sanofi Asthma; Inflammation Details
Bosakitug BSI-045B; TQC-2731; TQC2731 Phase 2 Clinical Biosion Inc Nasal Polyps; Sinusitis; Asthma; Dermatitis, Atopic Details
SHR-1905 SHR-1905; AIO-001 Phase 2 Clinical Shanghai Hengrui Pharmaceutical Co Ltd Nasal Polyps; Nose Diseases; Respiratory Tract Diseases; Sinusitis; Asthma Details
CM-326(Connaught Biomedical Technology) CM-326 Phase 2 Clinical Keymed Biosciences Co Ltd Nose Diseases; Nasal Polyps; Asthma; Sinusitis; Pulmonary Disease, Chronic Obstructive; Dermatitis, Atopic Details
PF-06342674 RN-168; PF-6342674; PF-06342674; ZB-168 Phase 1 Clinical Pfizer Inc Diabetes Mellitus, Type 1; Multiple Sclerosis Details
HBM-9378 SKB378; HBM-9378 Phase 1 Clinical Harbour Biomed, Sichuan Kelun-Biotech Biopharmaceutical Co Ltd Asthma Details
IBI-3002 IBI3002; IBI-3002 Phase 1 Clinical Innovent Biologics(Suzhou) Co Ltd Asthma Details
GB-0895 GB-0895 Phase 1 Clinical Generate Biomedicines Inc Immune System Diseases; Asthma Details
STSA-1201 STSA-1201; STSA1201 Phase 1 Clinical Staidson(Beijing) Biopharmaceuticals Co Ltd Asthma Details
LQ043H LQ043H Phase 1 Clinical Shanghai Novamab Biopharmaceuticals Co Ltd Asthma Details
GR2002 GR2002 Phase 1 Clinical Genrix (Shanghai) Biopharmaceutical Co Ltd Nasal Polyps; Asthma; Sinusitis; Dermatitis, Atopic Details
AZD-8630 AZD-8630; AMG-104 Phase 1 Clinical Astrazeneca Plc, Amgen Inc Asthma Details
QX-008N QX008N; QX-008N Phase 1 Clinical Qyuns Therapeutics Co Ltd Asthma; Pulmonary Disease, Chronic Obstructive Details
BD-9 BD-9 Biolojic Design Inc Details

This web search service is supported by Google Inc.

totop
Call us
Call us

Germany+49 800 0826645

United Kingdom+44 808 281 3436

Netherlands+31 800 0224992

Switzerland+41 800 040 012

France+33 800 90 78 85

Sweden+46 20 12 76 94

Denmark+45 80 83 07 62

Belgium+32 800 27 125

Email
Correo electrónico
order@acrobiosystems.com
Fax
Fax
+1 888-377-6111
Address
Address
Lichtstrasse 35,4056 Basel, Switzerland
linkedin twitter facebook youtube

Dejar un mensaje

Copyright © 2017 ACROBiosystems. All Rights Reserved
Related Links|Privacy Policy|Terms and Conditions|Legal|Sitemap